prismmarketview
Nov 4, 3:38 PM
$ENVB: EB-003 altered prefrontal and parietal brain-wave activity in mice (qEEG), distinct from DMT
→ No epileptic-like EEG activity or body spasms vs. DMT under study conditions
→ qEEG planned as a biomarker in first-in-human work
Caveats: preclinical. No doses or numbers disclosed. Human safety, efficacy, and non-hallucinogenic profile unproven. No Phase 1 date.
$ENVB #Psychedelics
https://prismmarketview.com/enveric-reports-distinct-brain-activity-profile-for-eb-003-in-preclinical-study/
0 replies